Indenix

A Primer On The Hepatitis C Market
Yahoo/Investors Business Daily
Fri, 07/4/14 - 11:53 am
hepatitis C
Gilead
Sovaldi
Merck
Victrelis
Incivek
Vertex Pharmaceuticals
Olysio
JNJ
AbbVie
Indenix
Bristol-Myers Squibb
Achillion May Be The Most Underrated Biotech Left
Seeking Alpha
Wed, 06/26/13 - 09:35 am
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Vertex Pharmaceuticals
Indenix
ACH-3102
ACH-1625
hepatitis C
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
biotech
M&A
Amarin
Achillion
ONYX Pharmaceuticals
Actelion
Elan
Forest Labs
Medivation
Biomarin
Indenix
Idenix tumbles on hepatitis drug safety concerns
Yahoo/AP
Thu, 08/16/12 - 11:54 am
Indenix
hepatitis C
IDX184
IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
Yahoo
Wed, 07/25/12 - 09:37 am
IDX719
fast track
FDA
Chronic Hepatitis C
hepatitis C
Indenix
Positive Data Released On Idenix Pharmaceuticals IDX184 Hep C Drug
Seeking Alpha
Wed, 06/20/12 - 11:50 am
Indenix
hepatitis C
IDX184
Keryx and Peers are Strong Buys
Motley Fool
Tue, 05/29/12 - 11:14 am
Keryx
Arena Pharmaceuticals
Dendreon
Novartis
Indenix
Spectrum Pharmaceuticals
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com
Tue, 04/24/12 - 10:36 am
cystic fibrosis
Vertex
Gilead
Bristol-Myers Squibb
Indenix
Kalydeco
VX-809
Why Idenix Pharmaceuticals Could Dive Further
Motley Fool
Fri, 04/13/12 - 08:26 am
Indenix
IDX184
hepatitis C
Bio-Pharma Watch List: 2 Week Report Card
Seeking Alpha
Mon, 03/12/12 - 05:30 pm
Spectrum Pharmaceuticals
Acadia
Antares Pharma
BioSante
Indenix
A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell
Seeking Alpha
Wed, 02/22/12 - 11:00 am
Antares
Bristol-Myers Squibb
Gilead
Indenix
Spectrum Pharmaceuticals
[video] Idenix Pharmaceuticals Is Looking For Partners
TheStreet.com
Thu, 02/16/12 - 05:23 pm
Indenix
M&A
Drugmakers Seek Deals to Gain Share of Future Hepatitis C Combination Pill
Bloomberg
Wed, 02/15/12 - 08:55 am
M&A
Inhibitex
Indenix
hepatitis C
Bristol-Myers Squibb
Achillion
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
BIO CEO Conference
Pfizer
Indenix
Keryx
Delcath
Oncothyreon
Acorda Therapeutics
Human Genome Sciences
Gilead
10 Biotech Stocks With Strong Corporate Governance
Seeking Alpha
Wed, 01/18/12 - 10:03 am
Amgen
Achillion
Chelsea Therapeutics
Charles River Laboratories
Indenix
Human Genome Sciences
Incyte
Immunogen
NPS Pharmaceuticals
PDL Biopharma
Analyzing 5 Biotech Stocks And Their Takeover Potential
Seeking Alpha
Fri, 01/13/12 - 10:33 am
Abbott Laboratories
Achillion
Alexion
Bristol-Myers Squibb
Gilead
GSK
Human Genome Sciences
Indenix
Inhibitex
JNJ
Pfizer
Vertex
Pharmasset
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Biotech Stocks At A Critical Juncture
Investopedia.com
Thu, 12/29/11 - 01:32 pm
Jazz Pharmaceuticals
Oncothyreon
Questcor
Indenix
Hep C Drug Panic! Pharmasset Stumble Ripples Through Sector
TheStreet.com
Fri, 12/16/11 - 11:29 am
Pharmasset
hepatitis C
Gilead
Inhibitex
PSI-938
Indenix
New Drug Approvals Make Or Break Biotechnology Stocks
Seeking Alpha
Wed, 11/30/11 - 10:46 am
Antares
Achillion
Pharmasset
Indenix
Inhibitex
ONYX Pharmaceuticals
Keryx

Pages